tibolone has been researched along with Low Bone Density in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Nofal, A; Alahdab, F; Almasri, J; Asi, N; Barrionuevo, P; Benkhadra, K; Farah, W; Haydour, Q; Kapoor, E; Mohammed, K; Murad, MH; Muthusamy, K; Sarigianni, M; Wang, Z | 1 |
| Arnold, A; Bartram, C; Ginsburg, J; Markou, A; Prelevic, GM; Puzigaca, Z | 1 |
| Adami, S; Davis, SR; Delmas, PD; Hensen, J; Nijland, EA; van Os, S | 1 |
| Hosoi, T; Ikegami, A; Kasugai, Y; Matsuo, K; Ohashi, M; Orimo, H; Ouchi, Y; Sukamoto, T | 1 |
| Kagawa, M; Kasugai, Y; Nakamura, T; Sukamoto, T; Yokota, K; Yoshitake, K | 1 |
1 review(s) available for tibolone and Low Bone Density
| Article | Year |
|---|---|
Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis.
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hip Fractures; Humans; Network Meta-Analysis; Norpregnenes; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause; Selective Estrogen Receptor Modulators; Spinal Fractures; Vitamin D | 2019 |
1 trial(s) available for tibolone and Low Bone Density
| Article | Year |
|---|---|
Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women.
Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Collagen Type I; Double-Blind Method; Female; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2008 |
3 other study(ies) available for tibolone and Low Bone Density
| Article | Year |
|---|---|
The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Bone Density; Bone Diseases, Metabolic; Calcium, Dietary; Cohort Studies; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Longitudinal Studies; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Treatment Outcome | 2004 |
Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
Topics: Administration, Oral; Amino Acids; Anabolic Agents; Animals; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Calcium; Cholesterol; Creatinine; Female; Femur; Humans; Hydroxyproline; Lumbar Vertebrae; Norpregnenes; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Weight Gain | 1998 |
Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Amino Acids; Anabolic Agents; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Calcium, Dietary; Cholecalciferol; Ethinyl Estradiol; Female; Norpregnenes; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Weight-Bearing | 1999 |